Zhenhai Yu

1.8k citations
46 papers · 1.3k indexed · h-index 24
Topics
Peptidase Inhibition and Analysis (12 papers)Cancer Mechanisms and Therapy (12 papers)Endometriosis Research and Treatment (11 papers)
Journals
Journal of Biological ChemistrySHILAP Revista de lepidopterologíaPLoS ONE
Partner nations
ChinaJapanUnited States

In The Last Decade

Zhenhai Yu

45 papers receiving 1.3k citations

Peers

Zhenhai Yu
Comparison fields: 5 of 96
  • Molecular Biology 751
  • Cancer Research 451
  • Oncology 274
  • Immunology 237
  • Reproductive Medicine 199
Replace Shulan Zhang with:
Shulan Zhang China
Chune Ren China
Oliver Treeck Germany
Verena Materna Germany
Youji Feng China
Peishu Liu China
Seiya Sato Japan
Ruixia Guo China
Yasuko Nishizawa Japan
Ashwini L. Chand Australia
Zhenhai Yu relative to Shulan Zhang China Shulan Zhang's profile →
Citations per field
00.5×4.6×
Shulan Zhang · 1×
Citations per year

Countries citing papers authored by Zhenhai Yu

Since Specialization
Citations

This map shows the geographic impact of Zhenhai Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhenhai Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhenhai Yu more than expected).

Fields of papers citing papers by Zhenhai Yu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhenhai Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhenhai Yu. The network helps show where Zhenhai Yu may publish in the future.

Co-authorship network of co-authors of Zhenhai Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Zhenhai Yu. A scholar is included among the top collaborators of Zhenhai Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhenhai Yu. Zhenhai Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 1
3 2
4 5
5 12
6 31
7 18
8 24
9 24
10 78
11 24
12 19
13 72
14 85
15 33
16 101
17 52
18 31
19 18
20 7

About Zhenhai Yu

Zhenhai Yu is a scholar working on Reproductive Medicine, Obstetrics and Gynecology and Pathology and Forensic Medicine, having authored 46 papers that have together received 1.3k indexed citations. Recurring topics across this work include Peptidase Inhibition and Analysis (12 papers), Cancer Mechanisms and Therapy (12 papers) and Endometriosis Research and Treatment (11 papers). The work is most often cited by research in Cancer Research (451 citations), Reproductive Medicine (199 citations) and Obstetrics and Gynecology (150 citations). Zhenhai Yu has collaborated with scholars based in China, Japan and United States. Frequent co-authors include Chune Ren, Pengyun Qiao, Tingting Yang, Xue Han, Yonghong Sun, Chao Lü, Li Wang, Shijun Lv, Liangqian Huang and Yu Du. Their work appears in journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026